Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
24.82
-0.01 (-0.04%)
Sep 16, 2026, 3:05 PM EDT - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.58 billion as of September 16, 2026. Its market cap has increased by 288.62% in one year.
Market Cap
2.58B
Enterprise Value
2.19B
1-Year Change
288.62%
Ranking
Category
Stock Price
$24.82
ChartMarket Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.58B, an increase of 265.84%. That is a compound annual growth rate of 23.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.58B | 33.95% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.81B |
| Immunome | 2.79B |
| Structure Therapeutics | 2.71B |
| Pharvaris | 2.68B |
| Disc Medicine | 2.61B |
| NewAmsterdam Pharma Company | 2.60B |
| Precigen | 2.53B |
| Mineralys Therapeutics | 2.51B |